Gland Pharma IPO allotment status: Two ways to check on BSE and Link Intime India
The Initial Public Offer (IPO) of Rs 6500 cr of Gland Pharma received good response from the investors. The issue was subscribed by 2.06 times. The share of retail investors got subscribed 24%, while the share on non-institutional investors got subscribed 51%. The company had set a price band of Rs 1490 – Rs 1500 per share for the IPO.
he largest IPO of the Pharma company has received good response from investors: Reuters